assistant professor

assistant professor

Dr. Jain on the Combination of Idelalisib and Rituximab for Older Patients With CLL

6h ago
SOURCE  

Description

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses the efficacy and safety of the combination of idelalisib and rituximab for older patients with chronic lymphocytic leukemia. More on hematologic malignancies: http://www.onclive.com/specialty/hematologic-cancer